Hiv /AIDS and other STDs
Order Description
Research a community health issue faced in Buffalo are,Western new York with specific attention paid to carefully outlining the problem, available statistics, casual related factors, a comprehensive description of a community level health intervention that could address the issue, and how you would evaluate the effect of that intervention. The key words here are COMMUNITY LEVEL. This shouldnot be an intervention that addresses individual behavior change directly but rather one that will impact at the level of the community.Your research can include sources outside of the target area,especially if it is from an area comparable to our area or facing similar community health issues. Submit an outline(including at least 10 references /citations in annotated format). These references should be mostly peer-reviewed ( scientific journals) but can be augmented with other media sources (newspaper, online reputable sources ).
You should include the following:
.Introduction (define the issue and rates,etc)
.Background (details about problem in particular area and current status of that community health issue )
.An overview of other intervention(s) from your literature search (including in other cities /regions )
.Your proposed intervention (who will it reach? How many people will be impacted? How long will it take? What does it involved? Who will carry it out? What key stakeholders will need to buy-in to it? Is it infrastructure, policy, environment, or program? Be creative! !).
.Your evaluation strategy -(How will you show that your intervention works? What sources of exist to help you measure the impact? What data might you have to collect to show the impact of the intervention? When and how often should you be measuring a certain health characters in the community? How will you measureit?
Outline are expected to be in standard outline form using appropriate numbers /letters to designate the position of concepts relative to each other. Within each section of the outline, cite the article that you will be be referencing to provide information in that section( citation should be authors’ name (s), date). At the end of your,provide the full citation including abstract if available ( taken directly from the article ). If no abstract is available, please write 1-2 sentences indicating what relevant information is included in the source. You should use APA format for citations followed by the abstract in paragraph form.
—

REVISION
Appendix 1: Example of the beginning of an outline/literature review on Alzheimer’s disease Title: Community Coping Efforts for Alzheimer’s Patients and Their Caretakers 1. Introduction a. Definition of the disease i. Symptoms (Dash and Villemarette, 2005; Ferris, 2011: 1; Lachaine et al, 2012: 597; Levy et al, 2012: 168; Opara, 2012: 162) 1. Loss of Cognitive Functions a. Loss of memory, confusion, progressive language impairment 2. Behavior and Mood Changes a. Depression, Anxiety, Aggression, Apathy, Hallucinations, Mood Swings, Agitation 3. Struggle To Complete Daily Activities b. Statement as to why Alzheimer’s Disease is a Community Concern i. Staggering rates ii. Monetary Cost iii. Negative Effects on Informal Caretakers c. Brief Summary of Organizations i. Alzheimer’s Association (www.alz.org/) ii. People Inc. (Member of Alzheimer’s Foundation of America) (http://www.alzfdn.org/index.htm) iii. Hospice Buffalo (www.hospicebuffalo.com/) iv. New York State Office for the Aging (http://www.aging.ny.gov/Index.cfm) Continued . . . . . Example of full citation with abstract (copied and pasted directly from the online journal source) Ferris, S.H., F.A. Schmitt, J. Saxton, S. Richardson, J. Mackell, Y. Sun, and Y. Xu. (2011). Analyzing the Impact of 23 mg/Day Donepezil on Language Dysfunction in Moderate to Severe Alzheimer’s Disease. Alzheimer’s Reasearch & Therapy, 3(3,) 1-8. Abstract Introduction Progressive language impairment is among the primary components of cognitive decline in Alzheimer’s disease (AD). Because expressive and receptive language help to maintain emotional connections to caregivers and support the management of AD patients’ functional needs, language plays a critical role in patients’ emotional and physical health. Using data from a large prospective clinical trial comparing two doses of donepezil in patients with moderate to severe AD, we performed a post hocanalysis to determine whether a higher dose of donepezil was associated with greater benefits in language function. Methods In the original randomized, double-blind clinical trial, 1,467 patients with moderate to severe AD (baseline Mini-Mental State Examination (MMSE) score 0 to 20) were randomized 2:1 to receive donepezil 23 mg/day or to continue on donepezil 10 mg/day for 24 weeks. In this post hoc analysis, the Severe Impairment Battery-Language scale (SIB-L) and a new 21-item SIB-derived language scale (SIB[lang]) were used to explore differences in language function between the treatment groups. Correlations between SIB-L and SIB[lang] scores and scores on the severe version of the Alzheimer’s Disease Cooperative Study-Activities of Daily Living inventory (ADCS-ADL-sev), the Clinician’s Interview-Based Impression of Severity-plus caregiver input/Clinician’s Interview-Based Impression of Change-plus caregiver input (CIBIS-plus/CIBIC-plus) and the MMSE were also investigated. Results At week 24, treatment with donepezil 23 mg/day was associated with an improvement in language in the full intention-to-treat population, whereas language function declined in the group treated with donepezil 10 mg/day (SIB-L treatment difference 0.8, P= 0.0013; SIB[lang] treatment difference 0.8, P = 0.0009). Similar results were observed in a cohort of patients with more severe baseline disease (MMSE score 0 to 16). At baseline and week 24, correlations between the SIB-derived language scales and the ADCS-ADL-sev and CIBIC-plus were moderate, but the correlations were stronger between the language scales and the MMSE scores. Conclusions Patients with moderate to severe AD receiving donepezil 23 mg/day showed greater language benefits than those receiving donepezil 10 mg/day as measured by SIB-derived language assessments. Increasing the dose of donepezil to 23 mg/day may provide language benefits in patients with moderate to severe AD, for whom preservation of language abilities is especially critical. ClinicalTrials.gov identifier: NCT00478205
Final Presentation Outline And Annotated Bibliography (10%) by April 18, 2016. These references should be mostly peer-reviewed (scientific journals) but can be augmented with other media sources (newspaper, online reputable sources). You should minimally include the following sections in your outline (and subsequent presentation): ï‚· Introduction (define the issue and the rates, etc.) ï‚· Background (details about problem in particular area and current status of that community health issue) ï‚· An overview of other intervention (s) from your literature search (including in other cities/regions) ï‚· Your proposed intervention (Who will it reach? How many people will be impacted? How long will it take? What does it involve? Who will carry it out? What key stakeholders will need to buy-in to it? Is it infrastructure, policy, environment, or a program? Be creative!!) ï‚· Your evaluation strategy –(How will you show that your intervention works? What sources of data exist to help you measure the impact? What data might you have to collect to show the impact of the intervention? When and how often should you be measuring a certain health characteristic in the community? How will you measure it? Be creative!!) Outlines are expected to be in standard outline form, using appropriate numbers/letters to designate the position of concepts relative to each other (see example in Appendix 1). Within each section of the outline, cite the article that you will be referencing to provide information in that section (citations should be authors’ name(s), date). At the end of your outline, provide the full citation including abstract if available (taken directly from the article). If no abstract is available, please write 1-2 sentences indicating what relevant information is included in the source. PLEASE NOTE THAT 1. INTRODUCTION, BACKGROUND AND PROPOSED INTERVENTION IS FINISH. PLEASE JUST FOCUS ON AN OVERVIEW OF OTHER INTERVENTIONS AND YOUR EVALUATION STRATEGY THANK YOU!

NO NEED TO WORK IN ANNOTATED BIBLIOGRAPHY

Hiv /AIDS and other STDs
Order Description
Research a community health issue faced in Buffalo are,Western new York with specific attention paid to carefully outlining the problem, available statistics, casual related factors, a comprehensive description of a community level health intervention that could address the issue, and how you would evaluate the effect of that intervention. The key words here are COMMUNITY LEVEL. This shouldnot be an intervention that addresses individual behavior change directly but rather one that will impact at the level of the community.Your research can include sources outside of the target area,especially if it is from an area comparable to our area or facing similar community health issues. Submit an outline(including at least 10 references /citations in annotated format). These references should be mostly peer-reviewed ( scientific journals) but can be augmented with other media sources (newspaper, online reputable sources ).
You should include the following:
.Introduction (define the issue and rates,etc)
.Background (details about problem in particular area and current status of that community health issue )
.An overview of other intervention(s) from your literature search (including in other cities /regions )
.Your proposed intervention (who will it reach? How many people will be impacted? How long will it take? What does it involved? Who will carry it out? What key stakeholders will need to buy-in to it? Is it infrastructure, policy, environment, or program? Be creative! !).
.Your evaluation strategy -(How will you show that your intervention works? What sources of exist to help you measure the impact? What data might you have to collect to show the impact of the intervention? When and how often should you be measuring a certain health characters in the community? How will you measureit?
Outline are expected to be in standard outline form using appropriate numbers /letters to designate the position of concepts relative to each other. Within each section of the outline, cite the article that you will be be referencing to provide information in that section( citation should be authors’ name (s), date). At the end of your,provide the full citation including abstract if available ( taken directly from the article ). If no abstract is available, please write 1-2 sentences indicating what relevant information is included in the source. You should use APA format for citations followed by the abstract in paragraph form.
—

REVISION
Appendix 1: Example of the beginning of an outline/literature review on Alzheimer’s disease Title: Community Coping Efforts for Alzheimer’s Patients and Their Caretakers 1. Introduction a. Definition of the disease i. Symptoms (Dash and Villemarette, 2005; Ferris, 2011: 1; Lachaine et al, 2012: 597; Levy et al, 2012: 168; Opara, 2012: 162) 1. Loss of Cognitive Functions a. Loss of memory, confusion, progressive language impairment 2. Behavior and Mood Changes a. Depression, Anxiety, Aggression, Apathy, Hallucinations, Mood Swings, Agitation 3. Struggle To Complete Daily Activities b. Statement as to why Alzheimer’s Disease is a Community Concern i. Staggering rates ii. Monetary Cost iii. Negative Effects on Informal Caretakers c. Brief Summary of Organizations i. Alzheimer’s Association (www.alz.org/) ii. People Inc. (Member of Alzheimer’s Foundation of America) (http://www.alzfdn.org/index.htm) iii. Hospice Buffalo (www.hospicebuffalo.com/) iv. New York State Office for the Aging (http://www.aging.ny.gov/Index.cfm) Continued . . . . . Example of full citation with abstract (copied and pasted directly from the online journal source) Ferris, S.H., F.A. Schmitt, J. Saxton, S. Richardson, J. Mackell, Y. Sun, and Y. Xu. (2011). Analyzing the Impact of 23 mg/Day Donepezil on Language Dysfunction in Moderate to Severe Alzheimer’s Disease. Alzheimer’s Reasearch & Therapy, 3(3,) 1-8. Abstract Introduction Progressive language impairment is among the primary components of cognitive decline in Alzheimer’s disease (AD). Because expressive and receptive language help to maintain emotional connections to caregivers and support the management of AD patients’ functional needs, language plays a critical role in patients’ emotional and physical health. Using data from a large prospective clinical trial comparing two doses of donepezil in patients with moderate to severe AD, we performed a post hocanalysis to determine whether a higher dose of donepezil was associated with greater benefits in language function. Methods In the original randomized, double-blind clinical trial, 1,467 patients with moderate to severe AD (baseline Mini-Mental State Examination (MMSE) score 0 to 20) were randomized 2:1 to receive donepezil 23 mg/day or to continue on donepezil 10 mg/day for 24 weeks. In this post hoc analysis, the Severe Impairment Battery-Language scale (SIB-L) and a new 21-item SIB-derived language scale (SIB[lang]) were used to explore differences in language function between the treatment groups. Correlations between SIB-L and SIB[lang] scores and scores on the severe version of the Alzheimer’s Disease Cooperative Study-Activities of Daily Living inventory (ADCS-ADL-sev), the Clinician’s Interview-Based Impression of Severity-plus caregiver input/Clinician’s Interview-Based Impression of Change-plus caregiver input (CIBIS-plus/CIBIC-plus) and the MMSE were also investigated. Results At week 24, treatment with donepezil 23 mg/day was associated with an improvement in language in the full intention-to-treat population, whereas language function declined in the group treated with donepezil 10 mg/day (SIB-L treatment difference 0.8, P= 0.0013; SIB[lang] treatment difference 0.8, P = 0.0009). Similar results were observed in a cohort of patients with more severe baseline disease (MMSE score 0 to 16). At baseline and week 24, correlations between the SIB-derived language scales and the ADCS-ADL-sev and CIBIC-plus were moderate, but the correlations were stronger between the language scales and the MMSE scores. Conclusions Patients with moderate to severe AD receiving donepezil 23 mg/day showed greater language benefits than those receiving donepezil 10 mg/day as measured by SIB-derived language assessments. Increasing the dose of donepezil to 23 mg/day may provide language benefits in patients with moderate to severe AD, for whom preservation of language abilities is especially critical. ClinicalTrials.gov identifier: NCT00478205
Final Presentation Outline And Annotated Bibliography (10%) by April 18, 2016. These references should be mostly peer-reviewed (scientific journals) but can be augmented with other media sources (newspaper, online reputable sources). You should minimally include the following sections in your outline (and subsequent presentation): ï‚· Introduction (define the issue and the rates, etc.) ï‚· Background (details about problem in particular area and current status of that community health issue) ï‚· An overview of other intervention (s) from your literature search (including in other cities/regions) ï‚· Your proposed intervention (Who will it reach? How many people will be impacted? How long will it take? What does it involve? Who will carry it out? What key stakeholders will need to buy-in to it? Is it infrastructure, policy, environment, or a program? Be creative!!) ï‚· Your evaluation strategy –(How will you show that your intervention works? What sources of data exist to help you measure the impact? What data might you have to collect to show the impact of the intervention? When and how often should you be measuring a certain health characteristic in the community? How will you measure it? Be creative!!) Outlines are expected to be in standard outline form, using appropriate numbers/letters to designate the position of concepts relative to each other (see example in Appendix 1). Within each section of the outline, cite the article that you will be referencing to provide information in that section (citations should be authors’ name(s), date). At the end of your outline, provide the full citation including abstract if available (taken directly from the article). If no abstract is available, please write 1-2 sentences indicating what relevant information is included in the source. PLEASE NOTE THAT 1. INTRODUCTION, BACKGROUND AND PROPOSED INTERVENTION IS FINISH. PLEASE JUST FOCUS ON AN OVERVIEW OF OTHER INTERVENTIONS AND YOUR EVALUATION STRATEGY THANK YOU!

NO NEED TO WORK IN ANNOTATED BIBLIOGRAPHY